DE69426570D1 - Mizelleförmige feinteilige pharmazeutische zusammensetzungen - Google Patents

Mizelleförmige feinteilige pharmazeutische zusammensetzungen

Info

Publication number
DE69426570D1
DE69426570D1 DE69426570T DE69426570T DE69426570D1 DE 69426570 D1 DE69426570 D1 DE 69426570D1 DE 69426570 T DE69426570 T DE 69426570T DE 69426570 T DE69426570 T DE 69426570T DE 69426570 D1 DE69426570 D1 DE 69426570D1
Authority
DE
Germany
Prior art keywords
microparticles
less
fatty acid
chain length
miscible
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69426570T
Other languages
English (en)
Other versions
DE69426570T2 (de
Inventor
Young W Cho
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Isomed Inc
Original Assignee
Isomed Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Isomed Inc filed Critical Isomed Inc
Application granted granted Critical
Publication of DE69426570D1 publication Critical patent/DE69426570D1/de
Publication of DE69426570T2 publication Critical patent/DE69426570T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69426570T 1993-11-03 1994-11-03 Mizelleförmige feinteilige pharmazeutische zusammensetzungen Expired - Fee Related DE69426570T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14674793A 1993-11-03 1993-11-03
PCT/US1994/012351 WO1995012385A1 (en) 1993-11-03 1994-11-03 Microparticular pharmaceutical compositions in micellar form

Publications (2)

Publication Number Publication Date
DE69426570D1 true DE69426570D1 (de) 2001-02-15
DE69426570T2 DE69426570T2 (de) 2001-08-23

Family

ID=22518831

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69426570T Expired - Fee Related DE69426570T2 (de) 1993-11-03 1994-11-03 Mizelleförmige feinteilige pharmazeutische zusammensetzungen

Country Status (10)

Country Link
EP (1) EP0726761B1 (de)
AT (1) ATE198547T1 (de)
CA (1) CA2175494C (de)
DE (1) DE69426570T2 (de)
DK (1) DK0726761T3 (de)
ES (1) ES2155512T3 (de)
GR (1) GR3035727T3 (de)
HK (1) HK1014150A1 (de)
PT (1) PT726761E (de)
WO (1) WO1995012385A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA9711731B (en) 1996-12-31 1998-07-01 Monsanto Co Aqueous glycerol formulations of somatotropin
ZA9711733B (en) * 1996-12-31 1998-07-01 Monsanto Co Method for solubilization and naturation of somatotropins
US5910319A (en) 1997-05-29 1999-06-08 Eli Lilly And Company Fluoxetine enteric pellets and methods for their preparation and use
CA2324403C (en) * 1999-01-18 2005-12-13 Lg Chemical Limited Lipophilic microparticles containing a protein drug or antigen and formulation comprising same
US6045826A (en) * 1999-04-02 2000-04-04 National Research Council Of Canada Water-soluble compositions of bioactive lipophilic compounds
US20080070981A1 (en) 2000-02-23 2008-03-20 Henryk Borowy-Borowski Water-soluble compositions of bioactive lipophilic compounds
US6632443B2 (en) 2000-02-23 2003-10-14 National Research Council Of Canada Water-soluble compositions of bioactive lipophilic compounds
AU7984200A (en) * 1999-09-21 2001-04-24 Skyepharma Canada Inc. Surface modified particulate compositions of biologically active substances
US7785625B2 (en) 2000-01-14 2010-08-31 Lg Life Sciences, Limited Lipophilic-coated microparticle containing a protein drug and formulation comprising same
EP1677792B1 (de) * 2003-10-31 2015-11-18 Takeda Pharmaceutical Company Limited Feste zubereitung mit pioglitazone, glimepiride und einem polyoxyethylen-sorbitan-fettsäureester
US7345093B2 (en) 2004-04-27 2008-03-18 Formatech, Inc. Methods of enhancing solubility of compounds
US7659310B2 (en) 2004-04-27 2010-02-09 Formatech, Inc. Methods of enhancing solubility of agents
EP1747782A1 (de) * 2005-07-19 2007-01-31 Cesare Montecucco Produkte zur topischen Anwendung enthaltend Lysophospholipide und Fettsäuren
US10143652B2 (en) 2009-09-23 2018-12-04 Curirx Inc. Methods for the preparation of liposomes
US9402812B2 (en) 2009-09-23 2016-08-02 Indu JAVERI Methods for the preparation of liposomes
US11278602B2 (en) 2020-03-25 2022-03-22 Therapeutica Borealis Oy Medicine for Covid-19 and treatment
US11638722B2 (en) 2020-03-25 2023-05-02 Therapeutica Borealis Oy C/O Avance Attorneys Ltd. Medicine for Covid-19 and treatment
WO2021191496A1 (en) * 2020-03-25 2021-09-30 Therapeutica Borealis Oy Medicine for covid-19 and treatment

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4993649A (en) * 1988-04-28 1991-02-19 Koenig Larry E Dual auger shredder
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
GB9007052D0 (en) * 1990-03-29 1990-05-30 Skua Investments Ltd Pharmaceutical formulations

Also Published As

Publication number Publication date
DE69426570T2 (de) 2001-08-23
WO1995012385A1 (en) 1995-05-11
HK1014150A1 (en) 1999-09-24
CA2175494A1 (en) 1995-05-11
ATE198547T1 (de) 2001-01-15
PT726761E (pt) 2001-07-31
ES2155512T3 (es) 2001-05-16
CA2175494C (en) 2000-09-19
DK0726761T3 (da) 2001-06-18
EP0726761A1 (de) 1996-08-21
GR3035727T3 (en) 2001-07-31
EP0726761B1 (de) 2001-01-10

Similar Documents

Publication Publication Date Title
DE69426570D1 (de) Mizelleförmige feinteilige pharmazeutische zusammensetzungen
Palin et al. The oral absorption of cefoxitin from oil and emulsion vehicles in rats
ES2185179T3 (es) Preparacion de composiciones farmaceuticas.
ID26221A (id) Komposisi-komposisi farmasi yang dapat dijadikan gel
NO20014719D0 (no) Orale farmasöytiske preparater inneholdende lang-kjedete triglyserider og lipofile overflateaktive midler
JP4209467B2 (ja) 経口投与用製剤組成物
FR2710840B1 (fr) Compositions viscoélastiques hautement concentrées en composés fluorés, leur préparation et leurs utilisations dans le domaine médical et en cosmétique.
DE3669106D1 (de) Pharmazeutische zusammensetzungen mit gehalt an flavanolignanen und phospholipiden als wirkstoffe.
DE60312193D1 (de) Pharmazeutische formulierung mit cyclosporin, propylenglycol-ester und nichtionischem tensid
JP6632837B2 (ja) 乳化組成物
JPS58206597A (ja) 水性燐脂質溶液
AR009651A1 (es) Composicion solubilizante/estabilizante anhidra, emulsionable o microemulsionable en agua, para la solubilizacion de los derivados hidrofobosde n-sulfonil indolina, composicion farmaceutica microemulsionable o emulsionable en medio acuoso, y capsulas farmaceuticas, particularmente blandas
KR930001903A (ko) 유비데카레논 경구용 수용액 제제
BRPI0516179A (pt) cápsulas de lercanidipina
FR2712809B1 (fr) Nouvelle composition pharmaceutique destinée à la préparation d'une poudre stable contenant, à titre d'ingrédient actif, une association d'acide acétylsalicylique et de métoclopramide.
ATE285782T1 (de) Pharmazeutische zusammensetzungen die ein alkylaryl polyether alkohol polymer enthalten
JPH07258070A (ja) 鼻洗浄剤
JPS60218318A (ja) 軟カプセル充填用組成物
JPS57109713A (en) Pharmaceutical preparation of combined agent of sulfamethoxazole and trimethoprim for medication through celom
NZ509593A (en) Compressed compositions comprising clarified xanthan gum
HU185533B (en) Process for producing concentrated hydrosoles containing h lipophilic and hydrophilic vitamines
KR960021036A (ko) 콜치신을 유효성분으로 함유하는 항간독성 조성물 및 그 제조방법
JPS6331443B2 (de)
DK146754B (da) Fremgangsmaade til fremstilling af vandige oploesninger af sterolglykosider eller esterderivater deraf

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee